Speciality Medicines SME IPO Details, Financials, Valuation & Peers
Explore Speciality Medicines SME IPO details, including IPO dates, financial statements, valuation, peer comparison and more.
Overview
Speciality Medicines Limited, incorporated in 2021, is engaged in the marketing and distribution of finished formulations of speciality pharmaceuticals.
Core Business: Marketing and distribution of finished pharmaceutical formulations.
Main Products/Services: The company's portfolio includes a wide range of speciality pharmaceutical finished formulations such as capsules, creams, eye drops, gels, infusions, inhalations and inhalers, injections, nasal sprays, ointments, ophthalmic solutions, oral solutions, oral suspensions, sachets, suspensions, and tablets. They also offer human and animal medicines, vaccines, and plasma products.
Industry Focus: High-cost oral and injectable medications used to treat complex chronic conditions, with a particular focus on therapeutic areas.
Key Highlights:
- Markets and distributes finished formulations of speciality pharmaceuticals across domestic and international markets.
- Offers over 650 products (as of July 31, 2024) under the unregistered category.
- Sources products from manufacturers that comply with global quality standards like EUGMP and PICS.
- Has built a trusted reputation with clients across more than 20 states in India and over 35 countries worldwide through wide-ranging distribution channels.
- Employs a team of 20 permanent employees across various departments.
Objects of the Issue
- Setting up of Research and Development (R&D) Centre at Revenue City Survey No. RV1/NA/61/1/50, Moje, Manda, Tal. Umargam, Dist. Valsad, Gujarat
- Product Registration in International Markets and Product Development for sale in international markets
- Funding for Marketing and Promotional Activities
- To Meet Working Capital Requirements
- General Corporate Purposes
- Total
IPO Details
Discover essential information crucial for understanding an IPO, including the Price Band, Fresh Issue, Offer For Sale, Total IPO Size and more. Explore these key details to gain insight into the company's public offering.
| Fields | Details |
|---|---|
| IPO Dates | 20 Mar - 24 Mar 2026 |
| IPO Price Band | ₹117 - ₹124 per share |
| Fresh Issue | 27.28 Cr |
| Offer For Sale | NIL |
| Total IPO Size | 27.28 Cr |
| Face Value | 10 |
| Listing On | BSE SME |
IPO Timeline
Explore important dates like IPO opening, closing, listing and others, outlining the journey of the Public Offering. This will help you grasp the entire IPO journey effortlessly.
| Event | Date |
|---|---|
| IPO Opening Date | 20 Mar 2026 |
| IPO Closing Date | 24 Mar 2026 |
| Basis Of Allotment | 25 Mar 2026 |
| Refunds | 27 Mar 2026 |
| Demat Transfer | 27 Mar 2026 |
| IPO Listing Date | 30 Mar 2026 |
Financial Statements
Explore a comprehensive financial data table showcasing key metrics including revenue, expenses, net income, and others. Gain valuable insights about the company's financial performance at a glance, facilitating informed decision-making and strategic planning for subscribing to the IPO.
| Period Ended | 31 Mar 2024 | 31 Mar 2025 | 31 Oct 2025 |
|---|---|---|---|
| Assets | 22.68 | 39.98 | 45.57 |
| Total Income | 27.66 | 58.54 | 36.93 |
| Profit After Tax | 2.93 | 8.61 | 6.06 |
| EBITDA | 5.26 | 9.09 | 6.51 |
| NET Worth | 15.06 | 30.42 | 36.47 |
| Reserves and Surplus | 9.95 | 23.98 | 30.04 |
| Total Borrowing | 2.86 | 5.05 | 4.81 |
* NPM represents the net profit margin, calculated as a percentage. All other figures are presented in crore (₹cr)
Peer Comparison
Compare key financial metrics with industry peers to gain valuable insights into the company's performance compared to its competitors.
| Name | P/E | EPS | RoNW | NAV |
|---|---|---|---|---|
| Speciality Medicines Ltd. | 8.79 | 14.1 | 28.42% | 47.26 |
| Mono Pharmacare Ltd. | 7.49 | 1.75 | 9.9% | 17.66 |
| Trident Lifeline Ltd. | 27 | 10.22 | 18.23% | 56.05 |
| Remus Pharmaceuticals Ltd. | 10.41 | 65.21 | 15.02% | 434.25 |
* Revenue in (₹cr), RoNW in (%), EPS, NAV in (₹). P/E ratio is based on the highest price from the IPO price band.
IPO Reservation
| Investor Type | Shares Offered |
|---|---|
| Qualified Institutional Buyer (QIB) | Not more than 2% of the Net Issue |
| Non-Institutional Investor (NII/HNI) | Not less than 49% of Net Issue |
| Retail Individual Investor (RII) | Not less than 49% of Net Issue |
Subscription Data from NSE and BSE
| Investor Type | Subscribed |
|---|---|
| Qualified Institutional Buyer (QIB) | 96.24 |
| Non-Institutional Investor (NII/HNI) | 1.88 |
| Retail Individual Investor (RII) | 0.85 |
| Total | 2.27 |
* All figures represent multiples of the subscription. Check subscriptions for other ongoing issues here.
IPO Registrar
MUFG Intime India Private Limited (Formerly known as Link Intime India Private Limited)
Phone: + 91 810 811 4949
Email: ipo.helpdesk@linkintime.co.in
Website: https://linkintime.co.in/
Lead Managers
- Unistone Capital Pvt.Ltd.
Company Address
Speciality Medicines Ltd.
913, One World West, S. No. 396, FP 119,
Village- Vejalpur, Ahmadabad City,
Ahmedabad, Gujarat, India,
Ahmedabad, Gujarat –380051
Website:https://www.specialitymedicine.com/
Phone:+91 22 4604 5344
Email:investors.grievances@specialitymedicine.com
FAQs
- What is the issue size of the Speciality Medicines SME IPO?The Speciality Medicines SME IPO has an issue size of 27.28 Cr. This includes a fresh issue of 27.28 Cr and an offer for sale (OFS) of NIL.
- What is the price band of the Speciality Medicines IPO?The price band for the Speciality Medicines IPO is ₹117 - ₹124 per share.
- What are the bidding dates for the Speciality Medicines IPO?The Speciality Medicines IPO will open for bidding on 20 Mar 2026 and close on 24 Mar 2026.
- What is the allotment date for the Speciality Medicines IPO?The allotment date for the Speciality Medicines IPO is 25 Mar 2026.
- What is the minimum lot size and investment required for the Speciality Medicines IPO?The minimum lot size for the Speciality Medicines IPO is 1000 shares and the minimum investment required is ₹1,24,000.
- What is the listing date for the Speciality Medicines IPO?The listing date for the Speciality Medicines IPO is 30 Mar 2026.
- What is the Speciality Medicines IPO grey market premium?The grey market premium (GMP) for the Speciality Medicines IPO is currently at ₹0, with an expected listing gain of approximately %. Remember, the grey market premium is not an official indicator, but it reflects market perception and demand for the IPO shares.